Hubei Province Key Laboratory of Allergy and Immunology, Department of Parasitology, Wuhan University School of Basic Medical Sciences, Wuhan, Hubei Province, China.
Hubei Provincial Center for Disease Control and Prevention, Wuhan, Hubei Province, China.
Parasitol Res. 2021 Jan;120(1):173-185. doi: 10.1007/s00436-020-06916-9. Epub 2020 Oct 20.
A vaccine is an important method to control schistosomiasis. Molecules related to lung-stage schistosomulum are considered potential vaccine candidates. We previously showed that glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and cathepsin L3 (CL3) displayed differential expression in the lung-stage schistosomula of Schistosoma japonicum cocultured with host cells. In the present study, we prepared the two proteins and detected the protective effects of SjGAPDH by immunizing mice with this protein alone and in combination with SjCL3 with or without Freund's adjuvant. Then, we investigated the possible mechanisms underlying S. japonicum infection. The results showed that vaccination of adjuvanted SjGAPDH decreased the worm burden (37.8%) and egg load (38.1%), and the combination of adjuvanted SjGAPDH and SjCL3 further decreased the worm burden (65.6%) and egg load (70.9%) during Schistosoma japonicum infection. However, the immunization of a combination of adjuvant-free SjGAPDH and SjCL3 displayed a lower protective effect (< 15%) than those of the adjuvanted SjCL3, the adjuvanted SjGAPDH, and a combination of adjuvanted SjGAPDH and SjCL3. Flow cytometric results showed that the frequency of regulatory T cells (Tregs) was lower (P < 0.05) in the group with adjuvanted SjGAPDH and SjCL3 (2.61%) than the remaining groups. The enzyme-linked immunosorbent assay (ELISA) results indicated that except for the uninfected and infected control groups, the remaining groups displayed a Th1-type shift in immune responses. These results showed the immunization of SjGAPDH resulted in partial protection (approximately 38%); inoculation with a combination of SjCL3 and SjGAPDH in Freund's adjuvant resulted in a high immunoprotective effect (> 65%) against Schistosoma japonicum infection in mice, which was possibly caused by the reduced percentage of Tregs and a Th1-type shift in immune responses; and SjCL3 has no adjuvant-like effect, dissimilar to SmCL3.
疫苗是控制血吸虫病的重要方法。与肺期血吸虫童虫相关的分子被认为是潜在的疫苗候选物。我们之前曾表明,甘油醛-3-磷酸脱氢酶(GAPDH)和组织蛋白酶 L3(CL3)在与宿主细胞共培养的日本血吸虫肺期童虫中显示出差异表达。在本研究中,我们制备了这两种蛋白质,并通过单独免疫小鼠以及用或不用弗氏佐剂与 SjCL3 联合免疫小鼠来检测 SjGAPDH 的保护作用。然后,我们研究了日本血吸虫感染的可能机制。结果表明,佐剂 SjGAPDH 疫苗接种可降低蠕虫负荷(37.8%)和卵负荷(38.1%),而佐剂 SjGAPDH 和 SjCL3 的组合进一步降低了蠕虫负荷(65.6%)和卵负荷(70.9%)。然而,佐剂免费的 SjGAPDH 和 SjCL3 的组合的免疫接种显示出比佐剂 SjCL3、佐剂 SjGAPDH 和佐剂 SjGAPDH 和 SjCL3 的组合更低的保护作用(<15%)。流式细胞术结果表明,佐剂 SjGAPDH 和 SjCL3 组(2.61%)的调节性 T 细胞(Tregs)频率较低(P<0.05)。酶联免疫吸附测定(ELISA)结果表明,除未感染和感染对照组外,其余组的免疫反应呈 Th1 型转变。这些结果表明,SjGAPDH 的免疫接种导致部分保护(约 38%);在弗氏佐剂中接种 SjCL3 和 SjGAPDH 的组合导致对小鼠日本血吸虫感染的高免疫保护作用(>65%),这可能是由于 Tregs 的百分比降低和免疫反应的 Th1 型转变所致;并且 SjCL3 没有佐剂样作用,与 SmCL3 不同。